A collaborative effort has developed a synthetic viral genome for bone cancer research and may prove revolutionary in the battle against cancer overall.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.

Berg is applying its technology to breast cancer samples gathered by a Department of Defense program.

Bayer has adopted Phlexglobal’s electronic trial master file system across most of its clinical trials.

The FDA has awarded a computational science and bioinformatics contract worth up to $112 million to Engility.

Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration

Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.

InVentiv Health has started using Veeva Systems’ study start-up application to accelerate trial site activation.

IT